Earnings History Data for ANI Pharmaceuticals, Inc. (ANIP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-02-2024	PM		ANIP	ANI Pharmaceuticals, Inc.	1,220	0.78	0.58	0.59	ANI Pharmaceuticals Non-GAAP EPS of $1.00, revenue of $131.7M [2/29/2024 6:55 AM]	67.71	7.43 (12.33%)	64.00	3.72 (6.17%)	36.54 - 70.50	733,852	90,000	2,628
ANI Pharmaceuticals 2H Earnings Preview [2/28/2024 11:59 AM] ANI Pharmaceuticals Non-GAAP EPS of $1.00, revenue of $131.7M [2/29/2024 6:55 AM]
08-11-2023	PM		ANIP	ANI Pharmaceuticals, Inc.	1,280	1.05	0.56	0.46	ANI Pharmaceuticals Non-GAAP EPS of $1.27 beats by $0.43, revenue of $131.83M beats by $19.91M [11/8/2023 6:51 AM]	54.28	-9.36 (-14.71%)	60.00	-3.64 (-5.72%)	32.16 - 65.89	925,039	140,000	12,143
ANI Pharmaceuticals Q3 2023 Earnings Preview [11/7/2023 12:38 PM] ANI Pharmaceuticals Non-GAAP EPS of $1.27 beats by $0.43, revenue of $131.83M beats by $19.91M [11/8/2023 6:51 AM]
09-08-2023	PM		ANIP	ANI Pharmaceuticals, Inc.	1,080	1.06	0.45	-0.05	ANI Pharmaceuticals Non-GAAP EPS of $1.28 beats by $0.61, revenue of $116.5M beats by $16.64M [8/9/2023 6:53 AM]	61.01	5.08 (9.08%)	61.60	5.67 (10.14%)	30.53 - 63.10	320,774	80,000	827
ANI Pharmaceuticals Q2 2023 Earnings Preview [8/8/2023 2:52 PM] ANI Pharmaceuticals Non-GAAP EPS of $1.28 beats by $0.61, revenue of $116.5M beats by $16.64M [8/9/2023 6:53 AM]
08-05-2023	PM	6:50 AM ET (May 8)	ANIP	ANI Pharmaceuticals, Inc.	681.56	0.97	0.13	-0.27	ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M [5/8/2023 6:56 AM]	42.51	3.37 (8.61%)	49.00	9.86 (25.19%)	22.31 - 52.23	383,767	40,000	6,114
ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M [5/8/2023 6:56 AM] ANI Pharmaceuticals soars ~10% after Q1 beat, raises outlook amid rare disease focus [5/8/2023 11:28 AM]
09-03-2023	PM	6:50 AM ET (Mar 9)	ANIP	ANI Pharmaceuticals, Inc.	715.78	0.59	0.49	0.38	ANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06M [3/9/2023 6:52 AM]	43.25	0.12 (0.28%)	0.0	0.0 (0.00%)	22.31 - 45.99	170,384	70,000	0
ANI Pharmaceuticals Q4 2022 Earnings Preview [3/8/2023 1:03 PM] ANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06M [3/9/2023 6:52 AM]
09-11-2022	PM	6:50 AM ET (Nov 9)	ANIP	ANI Pharmaceuticals, Inc.	666.37	0.46	0.40	0.83	ANI Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance [11/9/2022 6:56 AM]	34.73	-3.53 (-9.24%)	38.26	0.0 (0.00%)	22.31 - 51.69	197,521	50,000	1,712
ANI Pharmaceuticals Q3 2022 Earnings Preview [11/8/2022 12:27 PM] ANI Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance [11/9/2022 6:56 AM]
08-08-2022	PM	6:50 AM ET (Aug 8)	ANIP	ANI Pharmaceuticals, Inc.	547.24	-0.05	-0.04	0.49	ANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecast [8/8/2022 11:01 AM]	34.78	0.17 (0.48%)	36.00	1.38 (3.99%)	22.31 - 60.23	95,368	60,000	300
ANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for Cortrophin [8/8/2022 6:56 AM] ANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecast [8/8/2022 11:01 AM] ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates [Aug-08-22 08:05AM] ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel [Aug-08-22 06:50AM]
10-05-2022	PM	6:50 AM ET (May 10)	ANIP	ANI Pharmaceuticals, Inc.	473.60	-0.27	-0.05	0.92	ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M [5/10/2022 6:55 AM]	25.05	-1.07 (-4.10%)	25.01	-1.11 (-4.25%)	24.41 - 60.23	172,698	140,290	185
ANI Pharmaceuticals Q1 2022 Earnings Preview [5/9/2022 12:23 PM] ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M [5/10/2022 6:55 AM] Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 09:15AM] ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million [May-10-22 06:50AM] ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates [May-10-22 08:05AM]
15-03-2022	PM	6:45 AM ET (Mar 15)	ANIP	ANI Pharmaceuticals	530.00	0.38	0.82	0.00	ANI Pharmaceuticals GAAP EPS of $0.54 beats by $0.68, revenue of $60.9M beats by $4.6M [3/15/2022 6:54 AM]	28.48	-7.18 (-20.13%)	34.50	-1.16 (-3.25%)	0.0 - 0.0	969,477	0	4,053
ANI Pharmaceuticals Q4 2021 Earnings Preview [3/14/2022 12:23 PM] ANI Pharmaceuticals Non-GAAP EPS of $0.54 misses by $0.20, revenue of $60.9M beats by $4.6M [3/15/2022 6:54 AM] ANI Pharma reaches a seven-month low on soft guidance for 2022 [3/15/2022 10:27 AM] ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth [Mar-15-22 06:50AM] ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates [Mar-15-22 09:15AM] ANI Pharmaceuticals Down 25% After Earnings Miss [Mar-15-22 08:59AM]
01-11-2021	PM	7:25 AM ET (Nov 1)	ANIP	ANI Pharmaceuticals	494.00	0.83	0.71	0.00	ANI Pharmaceuticals EPS beats by $0.31, beats on revenue [11/1/2021 6:48 AM]	55.90	18.52 (49.53%)	42.74	5.36 (14.34%)	23.55 - 60.23	4,116,513	60,000	73,355
ANI Pharmaceuticals EPS beats by $0.31, beats on revenue [11/1/2021 6:48 AM] FDA grants expanded approval for ANI Pharmaceuticals' Cortrophin Gel [11/1/2021 6:46 AM] ANI Pharma surges 44% following strong earnings, expanded approval; hits 52-week high [11/1/2021 10:17 AM] ANI Pharmaceuticals Reports Third Quarter 2021 Results [Nov-01-21 06:45AM] ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome [Nov-01-21 06:30AM] ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021 [Oct-29-21 04:30PM] ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates [Nov-01-21 08:05AM] Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug [Nov-01-21 12:08PM] Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today [Nov-01-21 12:36PM] Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views [Nov-01-21 10:35AM] Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump [Nov-01-21 12:14PM] 40 Stocks Moving In Monday's Mid-Day Session [Nov-01-21 12:05PM] Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide [Nov-01-21 02:33PM]
06-08-2021	PM	6:50 AM ET (Aug 6)	ANIP	ANI Pharmaceuticals, Inc.	432.27	0.49	0.51	0.55	ANI Pharmaceuticals EPS beats by $0.07, beats on revenue [8/6/2021 7:38 AM]	32.86	-0.48 (-1.44%)	34.01	0.67 (2.01%)	23.55 - 40.00	36,763	60,000	295
ANI Pharmaceuticals EPS beats by $0.07, beats on revenue [8/6/2021 7:38 AM] ANI Pharmaceuticals Reports Second Quarter 2021 Results [Aug-06-21 07:24AM] ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates [Aug-06-21 08:45AM] ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript [Aug-06-21 02:31PM]
07-05-2021	PM	6:50 AM ET (May 7)	ANIP	ANI Pharmaceuticals, Inc.	426.11	0.92	0.58	0.89	ANI Pharmaceuticals EPS beats by $0.33, beats on revenue [5/7/2021 6:51 AM]	38.60	3.60 (10.29%)	38.60	0.0 (0.00%)	23.55 - 40.62	122,456	50,000	465
ANI Pharmaceuticals EPS beats by $0.33, beats on revenue [5/7/2021 6:51 AM] ANI Pharmaceuticals Reports First Quarter 2021 Results [May-07-21 06:50AM] ANI Pharmaceuticals, Inc. to Host Earnings Call [May-07-21 06:45AM] ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Top Estimates [May-07-21 08:05AM] ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript [May-07-21 11:30AM]
09-03-2021	PM	6:50 AM ET (Mar 9)	ANIP	ANI Pharmaceuticals, Inc.	364.57	0.65	0.85	0.93	ANI Pharmaceuticals EPS misses by $0.14, beats on revenue [3/9/2021 6:55 AM]	29.73	-0.61 (-2.01%)	0.0	0.0 (0.00%)	23.55 - 52.22	52,865	52,579	0
ANI Pharmaceuticals EPS misses by $0.14, beats on revenue [3/9/2021 6:55 AM] ANI Pharma to acquire Novitium expanding generics and CDMO business [3/9/2021 2:20 PM] ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth [Mar-09-21 06:50AM] ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business [Mar-09-21 06:45AM] ANI Pharmaceuticals, Inc. to Host Earnings Call [Mar-09-21 05:30AM] ANI Pharmaceuticals's Earnings: A Preview [Mar-08-21 10:18AM] ANI Pharmaceuticals (ANIP) Q4 Earnings Miss Estimates [Mar-09-21 08:05AM] ANI Pharmaceuticals Inc (ANIP) Q4 2020 Earnings Call Transcript [Mar-09-21 01:00PM]
05-11-2020	PM	6:50 AM ET (Nov 5)	ANIP	ANI Pharmaceuticals, Inc.	346.18	0.81	0.78	1.07	ANI Pharmaceuticals EPS beats by $0.09, beats on revenue [11/5/2020 6:56 AM]	26.66	-1.51 (-5.36%)	26.66	0.0 (0.00%)	25.00 - 80.16	100,838	64,129	501

06-08-2020	PM	8:30 AM ET (Aug 6)	ANIP	ANI Pharmaceuticals, Inc.	368.08	0.55	0.86	1.28	ANI Pharmaceuticals EPS misses by $0.06, beats on revenue [8/6/2020 6:53 AM]	29.38	-1.62 (-5.24%)	31.00	0.0 (0.00%)	25.23 - 84.16	39,490	107,280	116,263